Insider · CIK 0001867173
Douglas Carr
Files at IPSC (Century Therapeutics, Inc.). First filing Nov 5, 2024, latest Sep 15, 2026.
In brief
Douglas Carr files SEC Form 4 as officer at IPSC (Century Therapeutics, Inc.). Since Nov 5, 2024, Douglas Carr has reported 0 open-market buys worth $0 and 18 open-market sells worth $33k, the latest filed on Sep 15, 2026.
A track record needs three past buys with six months of prices behind them; Douglas Carr has 0, so none is measured yet.
The newest scored trade: sold $3,200 of IPSC on Sep 14, 2026, filed Sep 15, 2026, scored 23 (weak). In the last 12 months: 0 buys worth $0 and 11 sells worth $29k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IPSC: Century Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Century Therapeutics, Inc. | $3,200 1,658 shares | -0% | - | |
| 23Weak | Century Therapeutics, Inc. | $521 254 shares | -0% | - | |
| 15Weak | IPSCsell Century Therapeutics, Inc. | $544 275 shares | -0% | +326% from low-33% from high | |
| 23Weak | Century Therapeutics, Inc. | $3,692 1,654 shares | -0% | +384% from low-23% from high | |
| 23Weak | Century Therapeutics, Inc. | $526 249 shares | -0% | +356% from low-28% from high | |
| 15Weak | IPSCsell Century Therapeutics, Inc. | $618 264 shares | -0% | +392% from low-22% from high | |
| 23Weak | Century Therapeutics, Inc. | $18k 7,043 shares | -1% | +543% from low-15% from high | |
| 23Weak | Century Therapeutics, Inc. | $626 247 shares | -0% | +656% from low0% from high | |
| 15Weak | IPSCsell Century Therapeutics, Inc. | $589 323 shares | -0% | +373% from low-31% from high | |
| 23Weak | Century Therapeutics, Inc. | $137 257 shares | -0% | +47% from low-61% from high | |
| 23Weak | Century Therapeutics, Inc. | $171 292 shares | -0% | +54% from low-65% from high | |
| 30Weak | Century Therapeutics, Inc. | $132 263 shares | -0% | +31% from low-70% from high | |
| 15Weak | IPSCsell Century Therapeutics, Inc. | $158 296 shares | -0% | +45% from low-67% from high | |
| 30Weak | Century Therapeutics, Inc. | $3,050 4,904 shares | -1% | +61% from low-64% from high | |
| 30Weak | Century Therapeutics, Inc. | $162 295 shares | -0% | +44% from low-67% from high | |
| 30Weak | Century Therapeutics, Inc. | $763 1,240 shares | -0% | - | |
| 23Weak | Century Therapeutics, Inc. | $274 351 shares | -0% | - | |
| 23Weak | Century Therapeutics, Inc. | $347 283 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 14, 2026 | IPSC Century Therapeutics, Inc. | 1,658 0.00% of outstanding | $3,201 | Sep 14, 2026 | $1,064 |
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -1,658 | $1.93 | $3,200 | 502,907 | 28 d ago |
| Sep 8, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -254 | $2.05 | $521 | 504,565 | 34 d ago |
| Aug 3, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -275 | $1.98 | $544 | 504,819 | Aug 5, 2026 |
| Jun 12, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -1,654 | $2.23 | $3,692 | 505,094 | Jun 15, 2026 |
| Jun 8, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -249 | $2.11 | $526 | 506,748 | Jun 9, 2026 |
| May 4, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -264 | $2.34 | $618 | 506,997 | May 6, 2026 |
| Mar 12, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -7,043 | $2.55 | $18k | 507,261 | Mar 16, 2026 |
| Mar 9, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -247 | $2.54 | $626 | 514,304 | Mar 11, 2026 |
| Feb 3, 2026 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -323 | $1.82 | $589 | 514,551 | Feb 5, 2026 |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc. | AGrant or award Common Stock | +110,000 | $0.00 | $0 | 514,874 | Feb 4, 2026 |
| Feb 2, 2026 | IPSC Century Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Feb 4, 2026 |
| Dec 8, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -257 | $0.53 | $137 | 404,874 | Dec 10, 2025 |
| Nov 3, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -292 | $0.59 | $171 | 405,131 | Nov 5, 2025 |
| Sep 8, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -263 | $0.50 | $132 | 405,423 | Sep 10, 2025 |
| Aug 4, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -296 | $0.53 | $158 | 405,686 | Aug 6, 2025 |
| Jun 9, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -4,904 | $0.62 | $3,050 | 405,982 | Jun 11, 2025 |
| May 5, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -295 | $0.55 | $162 | 410,886 | May 7, 2025 |
| Mar 10, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -1,240 | $0.62 | $763 | 315,556 | Mar 12, 2025 |
| Mar 11, 2025 | IPSC Century Therapeutics, Inc. | AGrant or award Common Stock | +95,625 | $0.00 | $0 | 411,181 | Mar 12, 2025 |
| Mar 11, 2025 | IPSC Century Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +95,625 | $0.00 | $0 | 95,625 | Mar 12, 2025 |
| Feb 3, 2025 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -351 | $0.78 | $274 | 316,796 | Feb 5, 2025 |
| Nov 1, 2024 | IPSC Century Therapeutics, Inc. | FTax withholding Common Stock | -16,611 | $1.26 | $21k | 317,430 | Nov 5, 2024 |
| Nov 4, 2024 | IPSC Century Therapeutics, Inc. | SOpen-market sale Common Stock | -283 | $1.23 | $347 | 317,147 | Nov 5, 2024 |
Questions about Douglas Carr
Answered from the filings on this page, as of the latest one.
Is Douglas Carr buying or selling?
In the last 12 months Douglas Carr reported 0 open-market buys worth $0 and 11 open-market sells worth $29k on SEC Form 4; the latest was sold $3,200 of IPSC on Sep 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Douglas Carr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas Carr has 0.
Where does Douglas Carr file Form 4?
Douglas Carr has filed Form 4 at IPSC (Century Therapeutics, Inc.) as SVP Finance & Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.